May 6, 2024 | Diabetes Business, Featured, Foods, Research News, Technology Updates
Fully-implantable CGM receives FDA authorization for integration with insulin pumps by Jill Rollet for Healio.com/endocrinology, 30 April 2024. The Eversense E3 CGM (Senseonics Holdings and Ascensia Diabetes Care) received authorization to be marketed as an integrated...
Apr 29, 2024 | Advocacy, Diabetes Business, Featured, Foods, Research News
Introducing Cadisegliatin, a New Drug in the Type 1 Diabetes Pipeline by Ross Wollen for DiabetesDaily.com, 26 April 2024. Cadisegliatin, an investigative therapy currently entering phase 3 trials, could be the next important drug, after insulin, indicated for Type 1...
Apr 22, 2024 | Diabetes Business, Featured, Research News, Spotlight
JDRF Statement and Update on Insulin Shortage by JDRF.org/press-releases, April 2024. JDRF is aware that, unfortunately, individuals are having trouble filling their prescriptions for 10mL Humalog, 10mL Insulin Lispro, and 10mL Novolog vials. It is unacceptable that...
Apr 15, 2024 | A Little Humor, Advocacy, Diabetes Business, Research News, Technology Updates
Lilly’s Carelessness in Discontinuing 3 mL vials of Humalog Causes Shortages in 10 mL vials of Humalog + Unbranded Lispro by Scott Strumello for blog.sstrumello.com, 9 April 2024. In mid-March 2024, the JDRF shared news about how Eli Lilly & Company,...
Mar 25, 2024 | Diabetes Business, Exercise, Featured, Research News, Technology Updates
Eli Lilly warns of temporary short supply of two insulin products by Meg Tirrell for CNN.com/health, 22 March 2024. Drugmaker Eli Lilly warned that two of its formulations of insulin would be temporarily out of stock through the beginning of April, citing a “brief...